Hims & Hers Joins Hands with Former Rival, Hidden Concerns Loom Over the Weight Loss Drug Market Landscape Mar 18, 2026 Life Science
How is Pfizer Tackling the “Blockbuster Drug Drought” in the Post-Pandemic Era? Mar 17, 2026 Life Science
Insider Cashes Out, Hedge Fund Piles In: The Two Faces of Olema After a 300% Rally Mar 16, 2026 Life Science
Three Berkshire-Related Stocks Worth Watching: Chevron, Domino’s Pizza, and DaVita Mar 14, 2026 Consumer Goods, Life Science
Novo Nordisk Partners with Hims & Hers: Can Turning a Foe into a Friend Reverse the Downturn? Mar 13, 2026 Life Science
Is GeneDx, the Stock Cathie Wood Bought for 7 Straight Days, Actually Cheap? Mar 12, 2026 Life Science
The Obesity Drug War Goes Oral: Why Eli Lilly’s Orforglipron Could Steal the Spotlight from Novo Mar 11, 2026 Life Science
This Cathie Wood-Favored Gene-Editing Stock Is Up 47% This Year. Is It Poised to Take Off? Mar 8, 2026 Life Science
Alleviating Doctors’ Paperwork, Amazon Accelerates AI Healthcare Initiatives Mar 5, 2026 Life Science
